Dechra trades up after £100m capital increase
Shares in Dechra Pharmaceuticals, the UK veterinary pharmaceuticals company, closed 8.7% higher on Thursday after the company raised £105m of new capital to partly finance its acquisitions of AST Farma and Le Vet in the Netherlands.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts